EcoDrugPlus

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSMMMG00000019397
Gene Symbol: TRPV1
3 Cross references
134 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSMMMG00000002740
Gene Symbol: TSPO
3 Cross references
126 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSMMMG00000004814
Gene Symbol: TPH1
3 Cross references
255 Possible Orthologues:

Tubulin Alpha 1a

Ensembl ID : ENSMMMG00000023062
Gene Symbol: TUBA1A
3 Cross references
92 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSMMMG00000023064
Gene Symbol: TUBA1C
3 Cross references
119 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSMMMG00000020450
Gene Symbol: TUBA4A
3 Cross references
224 Possible Orthologues:

Tubulin Alpha-3 Chain

Ensembl ID : ENSMMMG00000001673
Gene Symbol: LOC107154696
2 Cross references
171 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSMMMG00000013513
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSMMMG00000014205
Gene Symbol: TUBB2B
3 Cross references
178 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSMMMG00000007969
Gene Symbol: TUBB3
1 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSMMMG00000019550
Gene Symbol: TUBB4A
3 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSMMMG00000008596
Gene Symbol: TUBB4B
3 Cross references
316 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).